Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin phosphate monotherapy in Chinese adults with type 2 diabetes mellitus
CTR20200172Phase 3Completed
- Sponsor
- Centaurus Biopharma
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Centaurus Biopharma. Started Feb 2020; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20200172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200172.